Diagnostics Signatures of Breast Cancer
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 2234
Special Issue Editor
Special Issue Information
Dear Colleagues,
Breast cancer (BC) is the most common malignancy among women worldwide. Its diagnosis is difficult due to different types of breast tumors. The new methods for the detection of BC are promising because they guarantee a precise targeted treatment of tumors. Current detection techniques for BC are very expensive and complicated, ultimately urging the need to develop easy-to-use and more sensitive strategies.
In the past decade, various histological and molecular studies confirmed the high heterogeneity in the nature of BC. During the progression of BC cells into malignancy, they exhibit various vital biomarkers that could be valuable in the diagnosis and treatment of BC. Advances in multiomics have also enabled the development of multigene assays to identify diagnostic signatures of BC. A biopsied sample goes through various multigene assays to predict the heterogeneity and recurrence score, providing complete information on the BC subtype involved. Many of these studies on multigene analyses projected the importance of integrating clinic–pathological information with multiomics data, and that this is likely to provide positive impacts on long-term patient outcomes.
We are pleased to invite you to submit a paper to this Special Issue, which will highlight more recent advances in methods of BC diagnosis, such as molecular signatures, micro-RNA, and bioinformatics methods. The aim of this Special Issue is to collect articles that highlight the currently available BC diagnostic strategies and those advanced ones based on molecular signatures or biomarkers being developed as state-of-the-art early screening and diagnostic technologies.
For this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Pathological diagnostic tools for breast cancer;
- Molecular diagnostics of breast cancer;
- Omics in breast cancer;
- Early diagnostics of BC.
We look forward to receiving your contributions.
Prof. Dr. Allal Ouhtit
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- biosensors
- early diagnosis
- omics
- multigene assays
- novel biomarkers
